Investigating five large population-based cohort studies to understand for the precursors of multimorbidity risk.
Lead Research Organisation:
CARDIFF UNIVERSITY
Department Name: School of Medicine
Abstract
Multimorbidity refers to different diseases being present at the same time in a person. For example, we know that almost half of people with a mental health disorder also have a long-term physical health problem and a third of people with a physical health problem have a psychiatric disorder. Life is often more difficult for people with both physical and psychiatric disorders. They can struggle to get the best possible care and are at risk of living less long.
We don't know enough about why multimorbidity happens. To fully understand why changes in physical and mental health happen over time we need large studies of people whose health has been followed over time. Studies of children are very important because they can tell us about early risks for development of multimorbidity later in life. This is important for creating the best plans to prevent at-risk children developing multimorbidity.
To really understand how multimorbidity develops, studies need to have information about the many important behaviours and events that can influence health. For example, we need to know about someone's living environment (e.g., low income), lifestyle (e.g., lack of exercise) or life events (e.g., stressful experiences).
We know that genes can increase risk of physical and psychiatric disorder. We also know that some groups in society are at greater risk of multimorbidity, such as people of Asian and Minority Ethnic groups and people who live in poverty. We don't currently understand why this is and in this study we aim to get answers by studying the development of physical and psychiatric disorders in children at genetic risk. To understand differences in multimorbidity development in people from different ethnic and socio-economic backgrounds, we need studies in which all these groups are well represented.
If we understand better how multimorbidity develops in different groups in society (people at genetic risk, those from different ethnic and socio-economic backgrounds) this will help doctors give patients care that is matched to their specific needs. It will also help doctors, schools and others prevent multimorbidity in at-risk children in ways that suit their backgrounds best.
Finally, to conduct these studies, a team of researchers with a range of expertise is needed, who together understand the range of physical and psychiatric disorders, as well as how genes, the living environment, life style and life events influence these disorders over time.
We are a team with wide-ranging medical and research expertise in physical and psychiatric disorders. We have brought together five very large studies in which the health of close to 700,000 people has been followed over time. Rich medical data is available, including from medical records. Other important information has also been collected such as on the living environment, lifestyle and life events of these people. Genetic information is also available for all people in these studies.
These studies follow the health over time of both adults and children. We can therefore study how physical and psychiatric disorders happen together in adulthood. Importantly we can then also study the early stages of the development of multimorbidity in children. Because our child and adult samples differ in ethnic and socio-economic background, we can also study if the development of multimorbidity differs for different groups in society. Finally, because we have genetic data we can study how genes influence multimorbidity development in people at risk.
Our study will help us understand how multimorbidity develops and which behaviours and events influence this. What we learn will be important for the prevention of multimorbidity in children who are at risk because of genetic, ethnic or economic reasons. We will create health messages for specific groups in society and this can reduce multimorbidity in at risk groups in the future.
We don't know enough about why multimorbidity happens. To fully understand why changes in physical and mental health happen over time we need large studies of people whose health has been followed over time. Studies of children are very important because they can tell us about early risks for development of multimorbidity later in life. This is important for creating the best plans to prevent at-risk children developing multimorbidity.
To really understand how multimorbidity develops, studies need to have information about the many important behaviours and events that can influence health. For example, we need to know about someone's living environment (e.g., low income), lifestyle (e.g., lack of exercise) or life events (e.g., stressful experiences).
We know that genes can increase risk of physical and psychiatric disorder. We also know that some groups in society are at greater risk of multimorbidity, such as people of Asian and Minority Ethnic groups and people who live in poverty. We don't currently understand why this is and in this study we aim to get answers by studying the development of physical and psychiatric disorders in children at genetic risk. To understand differences in multimorbidity development in people from different ethnic and socio-economic backgrounds, we need studies in which all these groups are well represented.
If we understand better how multimorbidity develops in different groups in society (people at genetic risk, those from different ethnic and socio-economic backgrounds) this will help doctors give patients care that is matched to their specific needs. It will also help doctors, schools and others prevent multimorbidity in at-risk children in ways that suit their backgrounds best.
Finally, to conduct these studies, a team of researchers with a range of expertise is needed, who together understand the range of physical and psychiatric disorders, as well as how genes, the living environment, life style and life events influence these disorders over time.
We are a team with wide-ranging medical and research expertise in physical and psychiatric disorders. We have brought together five very large studies in which the health of close to 700,000 people has been followed over time. Rich medical data is available, including from medical records. Other important information has also been collected such as on the living environment, lifestyle and life events of these people. Genetic information is also available for all people in these studies.
These studies follow the health over time of both adults and children. We can therefore study how physical and psychiatric disorders happen together in adulthood. Importantly we can then also study the early stages of the development of multimorbidity in children. Because our child and adult samples differ in ethnic and socio-economic background, we can also study if the development of multimorbidity differs for different groups in society. Finally, because we have genetic data we can study how genes influence multimorbidity development in people at risk.
Our study will help us understand how multimorbidity develops and which behaviours and events influence this. What we learn will be important for the prevention of multimorbidity in children who are at risk because of genetic, ethnic or economic reasons. We will create health messages for specific groups in society and this can reduce multimorbidity in at risk groups in the future.
Technical Summary
How can we provide targeted interventions that increase the probability of good long term physical and mental health? 46% of people with a mental health disorder have a long-term physical condition and 30% with a long-term physical condition have a mental health problem. The social and economic cost of this multimorbidity (MM) is substantial.
Understanding the nature of MM requires an approach that maps developmental trajectories, and needs a cross-disciplinary team with wide-ranging clinical and research expertise. Richly phenotyped longitudinal cohorts are needed to address the complex interplay between physical and mental health problems and interactions over time with socioeconomic position (SEP), lifestyle and life events.
Our cross-disciplinary team will bring together a unique resource of five large longitudinal population-based cohorts (total n~679,000), combining genome-wide data with highly detailed information on health, education and premorbid and current exposure factors. We will conduct highly powered analysis of MM trajectories in our adult cohorts, which will guide the study of early life precursors in our child cohorts.
Our cohorts are highly diverse in developmental stage (three multigenerational child cohorts and two adult cohorts); ethnic heritage; and SEP. This allows us to map MM across the lifespan in representative ethnic and socio-economic groups, addressing issues of confounding and bias associated with clinical cohorts, and providing insights to inform tailored interventions.
We will study the trajectories of population subgroups that are at high genetic risk of MM. We will include polygenic risk scores (PRS) for relevant traits in our models and explore genomic Copy Number Variants associated with neurodevelopmental disorders.
We will make our findings readily available to the research community and develop materials that will help a range of stakeholders better support those at elevated risk of MM.
Understanding the nature of MM requires an approach that maps developmental trajectories, and needs a cross-disciplinary team with wide-ranging clinical and research expertise. Richly phenotyped longitudinal cohorts are needed to address the complex interplay between physical and mental health problems and interactions over time with socioeconomic position (SEP), lifestyle and life events.
Our cross-disciplinary team will bring together a unique resource of five large longitudinal population-based cohorts (total n~679,000), combining genome-wide data with highly detailed information on health, education and premorbid and current exposure factors. We will conduct highly powered analysis of MM trajectories in our adult cohorts, which will guide the study of early life precursors in our child cohorts.
Our cohorts are highly diverse in developmental stage (three multigenerational child cohorts and two adult cohorts); ethnic heritage; and SEP. This allows us to map MM across the lifespan in representative ethnic and socio-economic groups, addressing issues of confounding and bias associated with clinical cohorts, and providing insights to inform tailored interventions.
We will study the trajectories of population subgroups that are at high genetic risk of MM. We will include polygenic risk scores (PRS) for relevant traits in our models and explore genomic Copy Number Variants associated with neurodevelopmental disorders.
We will make our findings readily available to the research community and develop materials that will help a range of stakeholders better support those at elevated risk of MM.
Organisations
- CARDIFF UNIVERSITY (Lead Research Organisation)
- Council of Scientific and Industrial Research (CSIR) (Collaboration)
- Centre of the Cell (Collaboration)
- Social Action for Health (Collaboration)
- European Cooperation in Science and Technology (COST) (Collaboration)
- Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer) (Collaboration)
- The Wellcome Trust Sanger Institute (Collaboration)
- Bradford Institute for Health Research (BIHR) (Collaboration)
- The Lundbeck Foundation Initiative for Integrative Psychiatric Research (Collaboration)
- Cardiff University (Collaboration)
- East London Genes and Health (Collaboration)
- Stanford Medicine (Collaboration)
- UNIVERSITY OF BIRMINGHAM (Collaboration)
- Norwegian Institute of Public Health (Collaboration)
- University of Bristol (Collaboration)
- University College London (Collaboration)
- UNIVERSITY OF NOTTINGHAM (Collaboration)
- Ministry of Housing, Communities and Local Government (Collaboration)
- Norwegian Mother and Child Cohort (MoBa) (Collaboration)
- Newcastle University (Collaboration)
- Bradford Metropolitan District Council (Collaboration)
- DEPARTMENT FOR EDUCATION (Collaboration)
- IMPERIAL COLLEGE LONDON (Collaboration)
- UNIVERSITY OF CAMBRIDGE (Collaboration)
- UNIVERSITY OF EXETER (Collaboration)
- UNIVERSITY OF OXFORD (Collaboration)
- Alan Turing Institute (Collaboration)
- London School of Hygiene and Tropical Medicine (LSHTM) (Collaboration)
- King Edward Memorial Hospital Research Centre (Collaboration)
- National Center for Mental Health (NCMH) (Collaboration)
- National Institutes of Health (NIH) (Collaboration)
Publications
Calle Sánchez X
(2022)
Comparing Copy Number Variations in a Danish Case Cohort of Individuals With Psychiatric Disorders.
in JAMA psychiatry
Donnelly NA
(2022)
Childhood immuno-metabolic markers and risk of depression and psychosis in adulthood: A prospective birth cohort study.
in Psychoneuroendocrinology
Edmondson-Stait A
(2022)
Early-life inflammatory markers and subsequent psychotic and depressive episodes between 10 to 28 years of age
in Brain, Behavior, & Immunity - Health
Foley E
(2022)
Peripheral blood cellular immunophenotype in depression: A systematic review and meta-analysis
in Brain, Behavior, and Immunity
Foley ÉM
(2023)
Peripheral blood cellular immunophenotype in depression: a systematic review and meta-analysis.
in Molecular psychiatry
Hamilton FW
(2023)
Therapeutic potential of IL6R blockade for the treatment of sepsis and sepsis-related death: A Mendelian randomisation study.
in PLoS medicine
Kaser M
(2022)
Neurocognitive Performance in Depressed Patients with low-grade inflammation and somatic symptoms
in Brain, Behavior, & Immunity - Health
Krebs MD
(2021)
Associations between patterns in comorbid diagnostic trajectories of individuals with schizophrenia and etiological factors.
in Nature communications
Title | Act Early: Holme Wood |
Description | A film that captures the work undertaken to connect data scientists with the Holme Wood community. |
Type Of Art | Film/Video/Animation |
Year Produced | 2022 |
Impact | The video was used to engage senior policy makers from the District to attend a meal organised by the research team to explore how the insights from the data science projects could be used to improve lives for people in the area. |
URL | https://drive.google.com/file/d/19S0_2KrutRKxqows1kDwy0M0yaW-3Uaw/view |
Description | BRIDGE programme lecture in Precision Medicine at Copenhagen University |
Geographic Reach | Multiple continents/international |
Policy Influence Type | Influenced training of practitioners or researchers |
Impact | Educating researchers in medical science about precision medicine. |
Description | Department of Health and Social Care workshop on access to mental health services in children and young people with rare conditions |
Geographic Reach | National |
Policy Influence Type | Participation in a guidance/advisory committee |
Description | Dr Megan Wood and Prof Mark Mon-Williams - Gave evidence for Child of the North APPG in Westminster |
Geographic Reach | National |
Policy Influence Type | Participation in a guidance/advisory committee |
Description | Electronic Vulnerability Index task force |
Geographic Reach | National |
Policy Influence Type | Membership of a guideline committee |
Description | Genetic research in psychiatric practice |
Geographic Reach | National |
Policy Influence Type | Influenced training of practitioners or researchers |
Impact | Taught specialists in psychiatric practice regarding the role on genetics and genetic research in improving patient diagnosis and care. |
Description | Input into the National Special Educational Needs and Disabilities (SEND) Review and Autism Strategy Department for Education. |
Geographic Reach | National |
Policy Influence Type | Contribution to a national consultation/review |
Description | LINC Collaborative meeting with NIHR/ DHSC to discuss future funding priorities for multimorbidity research |
Geographic Reach | National |
Policy Influence Type | Participation in a guidance/advisory committee |
Description | Multi stakeholder workshop on genomics in education |
Geographic Reach | National |
Policy Influence Type | Participation in a guidance/advisory committee |
Description | Panel member in forum 'Tackling structural inequalities & championing evidential approaches, to improve the life chances of children in Bradford and beyond' event. |
Geographic Reach | National |
Policy Influence Type | Participation in a guidance/advisory committee |
URL | https://caer.org.uk/events/tackling-structural-inequalities-championing-evidential-approaches-to-imp... |
Description | Presentation about heredatibility and Evolution of Mental Health Disorders |
Geographic Reach | National |
Policy Influence Type | Influenced training of practitioners or researchers |
Impact | Improving the knowledge and understanding of psychiatrists of mental health disorders in patients. |
Description | Report to Welsh Assembly Parliamentary Event for Rare Disease Day summarizing our research on mental health conditions in people with rare genetic conditions. |
Geographic Reach | National |
Policy Influence Type | Implementation circular/rapid advice/letter to e.g. Ministry of Health |
URL | https://geneticalliance.org.uk/wp-content/uploads/2021/02/Genetic-Alliance-Wales-CPG-Report-Final.pd... |
Description | Teaching neurogenetics on Master's in Neuroscience at Copenhagen University |
Geographic Reach | National |
Policy Influence Type | Influenced training of practitioners or researchers |
Impact | Increasing knowledge and awareness of researchers in neuroscience of the influence of genetics on psychiatric outcomes. |
Description | Training practitioners in children and adolescent psychiatry |
Geographic Reach | National |
Policy Influence Type | Influenced training of practitioners or researchers |
Impact | Teaching specialists in child and adolescent mental health. |
Description | deCODE-CHB/DBDS workshop |
Geographic Reach | Europe |
Policy Influence Type | Participation in a guidance/advisory committee |
Impact | The research aims to improve patient care, diagnostics and treatment and further scientific research and discoveries in the field of biomedical acience. |
Description | Investigating physical and mental health multi-morbidity determinants throughout the lifespan. |
Amount | £66,000 (GBP) |
Organisation | Health and Care Research Wales |
Sector | Public |
Country | United Kingdom |
Start | 01/2023 |
End | 12/2025 |
Description | Investigating physical and mental health multimorbidity determinants throughout the lifespan. |
Amount | £66,000 (GBP) |
Funding ID | HS-22-04 |
Organisation | Health and Care Research Wales |
Sector | Public |
Country | United Kingdom |
Start | 01/2023 |
End | 12/2025 |
Description | MLTC-M Community of Practice in ECR training on best practice patient and public involvement with diverse populations |
Amount | £48,902 (GBP) |
Funding ID | MR/X004341/1 |
Organisation | Medical Research Council (MRC) |
Sector | Public |
Country | United Kingdom |
Start | 06/2022 |
End | 01/2024 |
Description | Physical and mental health multimorbidity across the lifespan (LIfespaN multimorbidity research Collaborative (LINC)). |
Amount | £3,034,322 (GBP) |
Funding ID | MR/W014416/1 |
Organisation | Medical Research Council (MRC) |
Sector | Public |
Country | United Kingdom |
Start | 12/2021 |
End | 11/2025 |
Description | Using artificial intelligence (AI) to characterize the dynamic inter-relationships between MUltiple Long-term condiTIons and PoLYpharmacy and across diverse UK populations and inform health care pathways (AI-MULTIPLY). AIM Research Collaboration |
Amount | £2,971,000 (GBP) |
Funding ID | NIHR 31672 |
Organisation | National Institute for Health Research |
Sector | Public |
Country | United Kingdom |
Start | 03/2022 |
End | 11/2025 |
Title | A pipeline to automate the production of individual Flexible Data Model (FDM) datasets |
Description | We have prototyped and are currently testing a, pipeline to automate the production of individual Flexible Data Model (FDM) datasets within the Connected Yorkshire cloud storage platform. We have developed a python API to facilitate this pipeline - the API automatically generates master tables and updates raw data to facilitate the FDM and the proposed aim of rapidly generating cohorts. The API is designed so that it can be extended in the future to handle raw data uploads to the cloud platform and the "delta" update process for frequently updated datasets - the aim is for this automated process to streamline the many disjoint manual processes that are currently underway to generate and maintain the cohorts/datasets, and save many-many hours of work in the process. |
Type Of Material | Improvements to research infrastructure |
Year Produced | 2022 |
Provided To Others? | No |
Impact | The development of this method is helping us drive forward discussions about connecting datasets across the whole of West Yorkshire |
Title | Cohort Creation Library for The Observational Medical Outcomes Partnership Common Data Model |
Description | When carrying out medical studies, a cohort of patients that are of interest for the study need to be retrieved from a database. However, this process takes an unvaried amount of time, as retrieving the correct information from a standardised database is time consuming. This is because definitions for cohorts can differ considerably, e.g. patients with chronic obstructive pulmonary disease, or children suffering from asthma. |
Type Of Material | Improvements to research infrastructure |
Year Produced | 2021 |
Provided To Others? | Yes |
Impact | The project has created a library that allows the creation of cohorts from a standardised medical database, the OMOP CDM, as quickly and as easily as possible from OMOP concepts and other simple cohort definitions. Analysis scripts have been created to generate summary statistics and graphs of the data, in order to outline the data as quickly as possible so that analysis can be undertaken. |
Title | Bradford Data Science Repository |
Description | A combined dataset that allows Data Science to Explore and Translate the Public Service Needs in Bradford |
Type Of Material | Database/Collection of data |
Year Produced | 2020 |
Provided To Others? | Yes |
Impact | The dataset is allowing our different communities (including the people who live in Bradford) to start exploring the data that describe the locality, |
URL | https://databradford.com/ |
Title | Connected Bradford |
Description | We have used the award to push forward linkage of all the health and education records across Bradford. This has required a data extract from the National Pupil Database and discussions with the Department for Education (including meetings with the Director of Strategy at the DfE). We now have the permissions to undertake this linkage and this will provide one of the most comprehensive datasets linking health and education in the UK (if not the most comprehensive). |
Type Of Material | Database/Collection of data |
Year Produced | 2020 |
Provided To Others? | No |
Impact | The database will be finalised over the next few months and will then be open access (via the same mechanisms used for accessing Born in Bradford data). |
Title | Genes & Health |
Description | A large resource of genomic and linked electronic health record data on Genes & Health volunteers (currently 54k). |
Type Of Material | Database/Collection of data |
Year Produced | 2017 |
Provided To Others? | Yes |
Impact | Wide academic collaborations and research studies |
URL | http://www.genesandhealth.org |
Title | MULTIPLY long term conditions open access codelist resource |
Description | Most research on multimorbidity, to date, includes a maximum of 30-40 long-term conditions based heavily on the Quality Outcomes Framework in primary care, and seminal papers by, e.g. Barnett et al. We have developed MULTIPLY, a detailed clinical consensus-building exercise to define ~200 conditions for inclusion in multimorbidity studies, particularly suited to data-driven projects using real world data. We have undertaken detailed clinical curation of these codelists (across linked primary and secondary care datasets) using existing codelist resources, e.g. from CPRD, CALIBER and adding our own detailed and structured clinical review. The codelists are interoperable across different primary care software systems. Our MULTIPLY codelists are now available in an open access GitHub (https://github.com/f-eto/MULTIPLY-Initiative) with the following DOI ( https://doi.org/10.5281/zenodo.7643566) |
Type Of Material | Database/Collection of data |
Year Produced | 2022 |
Provided To Others? | Yes |
Impact | Our MULITPLY codelists are already being used by several other large UKRI-funded research studies, including AI-MULTIPLY, LINC multimorbidity and Gene & Health. |
Description | ALSPAC |
Organisation | University of Bristol |
Department | Avon Longitudinal Study of Parents and Children (ALSPAC) |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Enhanced links between research institutions: Cardiff University, Leeds University, Queen Mary University London, Copenhagen University, Exeter University, Wellcome Sanger Institute. Enhanced links between research cohorts Genes and Health (G&H); Born in Bradford (BiB) and Danish Integrative Psychiatric Research (iPSYCH) studies. |
Collaborator Contribution | The ALSPAC cohort is one of the five research cohorts our Research Collaborative will conduct research in. ALSPAC/ Bristol researchers have made significant contributions to the development of our Research Collaborative grant proposal. |
Impact | Collaborative grant proposal submitted. |
Start Year | 2020 |
Description | BiB |
Organisation | Bradford Institute for Health Research (BIHR) |
Department | Born in Bradford |
Country | United Kingdom |
Sector | Public |
PI Contribution | Enhanced links between research institutions: Cardiff University, Bristol University, Queen Mary University London, Copenhagen University, Exeter University, Wellcome Sanger Institute. Enhanced links between research cohorts Genes and Health (G&H); Avon Longitudinal Study of Parents and Children (ALSPAC), and Danish Integrative Psychiatric Research (iPSYCH) studies. We have called the CNVs in half of the BiB sample (children and parents) already. |
Collaborator Contribution | The BiB cohort is one of the five research cohorts our Research Collaborative will conduct research in. BiB/ Leeds researchers have made significant contributions to the development of our Research Collaborative grant proposal. |
Impact | Collaborative grant proposal submitted. |
Start Year | 2016 |
Description | Bradford City Municipal District Council partnership |
Organisation | Bradford Metropolitan District Council |
Country | United Kingdom |
Sector | Public |
PI Contribution | We are working directly with the Local Authority to ensure that the findings are used to drive policies across the District. |
Collaborator Contribution | BCMDC are sponsoring the work through the Director of Children's Services (Mark Douglas) who is chairing the executive steering group and activating his teams to support the research. |
Impact | We have created a series of working groups including a 'practitioner' group comprising the relevant stakeholders from across the Local Authority. |
Start Year | 2020 |
Description | Covid response partnership with the Centre for Population Health Sciences Stanford University |
Organisation | Stanford Medicine |
Country | United States |
Sector | Hospitals |
PI Contribution | We have hosted joint webinars to support health and education provision through the school systems in California and Yorkshire. We have brought our academic expertise and datasets to help shed light on the major factors affecting children and young people because of the pandemic. Our academics have provided research expertise to the collaboration. |
Collaborator Contribution | They have directly funded joint research projects tackling: (i) the digital divide; (ii) food insecurity and obesity; (iii) educational inequalities; (iv) mental health. Their academics have joined our research team to provide expertise. |
Impact | We have produced a joint report between the collaborators - a report that has been shared with our colleagues in local and central government. |
Start Year | 2020 |
Description | DECIPHer |
Organisation | Centre for the Development and Evaluation of Complex Interventions for Public Health Improvement (DECIPHer) |
Country | United Kingdom |
Sector | Public |
PI Contribution | Our Research Collaborative has discussed our plans with DECIPHer and thus increased awareness of the role of childhood risk factors for the development of internalizing disorder and cardiometabolic disorder multimorbidity later in life. |
Collaborator Contribution | DECIPHer will contribute to our Research Collaborative by sharing experiences about prevention and intervention development. DECIPHer is committed to providing expertise in how successful interventions can be developed based on the findings our Research Collaborative will generate. Our Research Collaborative would partner with DECIPHer for future funding to do so. DECIPHer will also provide access to their wide-ranging networks of policy makers, practitioners and young people. |
Impact | This is a multidisciplinary collaboration which involves mental health, physical health, genetics, epidemiology and intervention development. |
Start Year | 2012 |
Description | DEMISTIFI-Multi Morbidity Consortium |
Organisation | University of Nottingham |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | We will enable opportunities for the DEMISTIFI-Multi Morbidity Consortium for further research of genetic risk factors for multi-organ fibrosis in our cohorts. |
Collaborator Contribution | The DEMISTIFI-Multi Morbidity Consortium will allow us to extend our collaborations and allow us to apply our analytical strategies to new multimorbidity clusters. |
Impact | Discussions about collaborations |
Start Year | 2021 |
Description | DEMISTIFY multimorbidity Collaborative |
Organisation | Imperial College London |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | We have joined each others conferences and have discussions about collaboration |
Collaborator Contribution | We have joined each others conferences and have discussions about collaboration |
Impact | Discussions |
Start Year | 2020 |
Description | East London Genes and Health (ELGH) |
Organisation | Centre of the Cell |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | I am deputy lead for this large community genomics study. I contribute towards the overall running of this important study (including recruitment, study design and management, recall-by-genotype, community engagement) which is a large community genomics project of British Bangladeshis and Pakistanis (n=28,000). I am also the local PI for a UK consortium studying type 2 diabetes in this cohort, including running recall-by-genotype studies, analysis of big data (using electronic health records) and the design of future metabolic phenotyping studies. |
Collaborator Contribution | ELGH works with a large international consortium (including academic and industry partners) involved in many of its activities. I am working particularly with a UK-wide consortium of diabetes researchers in recall-by-genotype studies based on rare diabetes and obesity-associated variants. |
Impact | Currently this is work in progress and we are in the recruitment phase to recall-by-genotype studies. We have a broad range of multidisciplinary partnerships involved in our community engagement and outreach activities, including close work with community-based organisations (e.g. https://www.safh.org.uk) and engagement workshops involving anthropologists and experts in public engagement (https://www.centreofthecell.org). |
Start Year | 2017 |
Description | East London Genes and Health (ELGH) |
Organisation | Imperial College London |
Department | Faculty of Medicine |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | I am deputy lead for this large community genomics study. I contribute towards the overall running of this important study (including recruitment, study design and management, recall-by-genotype, community engagement) which is a large community genomics project of British Bangladeshis and Pakistanis (n=28,000). I am also the local PI for a UK consortium studying type 2 diabetes in this cohort, including running recall-by-genotype studies, analysis of big data (using electronic health records) and the design of future metabolic phenotyping studies. |
Collaborator Contribution | ELGH works with a large international consortium (including academic and industry partners) involved in many of its activities. I am working particularly with a UK-wide consortium of diabetes researchers in recall-by-genotype studies based on rare diabetes and obesity-associated variants. |
Impact | Currently this is work in progress and we are in the recruitment phase to recall-by-genotype studies. We have a broad range of multidisciplinary partnerships involved in our community engagement and outreach activities, including close work with community-based organisations (e.g. https://www.safh.org.uk) and engagement workshops involving anthropologists and experts in public engagement (https://www.centreofthecell.org). |
Start Year | 2017 |
Description | East London Genes and Health (ELGH) |
Organisation | Social Action for Health |
Country | United Kingdom |
Sector | Charity/Non Profit |
PI Contribution | I am deputy lead for this large community genomics study. I contribute towards the overall running of this important study (including recruitment, study design and management, recall-by-genotype, community engagement) which is a large community genomics project of British Bangladeshis and Pakistanis (n=28,000). I am also the local PI for a UK consortium studying type 2 diabetes in this cohort, including running recall-by-genotype studies, analysis of big data (using electronic health records) and the design of future metabolic phenotyping studies. |
Collaborator Contribution | ELGH works with a large international consortium (including academic and industry partners) involved in many of its activities. I am working particularly with a UK-wide consortium of diabetes researchers in recall-by-genotype studies based on rare diabetes and obesity-associated variants. |
Impact | Currently this is work in progress and we are in the recruitment phase to recall-by-genotype studies. We have a broad range of multidisciplinary partnerships involved in our community engagement and outreach activities, including close work with community-based organisations (e.g. https://www.safh.org.uk) and engagement workshops involving anthropologists and experts in public engagement (https://www.centreofthecell.org). |
Start Year | 2017 |
Description | East London Genes and Health (ELGH) |
Organisation | The Wellcome Trust Sanger Institute |
Country | United Kingdom |
Sector | Charity/Non Profit |
PI Contribution | I am deputy lead for this large community genomics study. I contribute towards the overall running of this important study (including recruitment, study design and management, recall-by-genotype, community engagement) which is a large community genomics project of British Bangladeshis and Pakistanis (n=28,000). I am also the local PI for a UK consortium studying type 2 diabetes in this cohort, including running recall-by-genotype studies, analysis of big data (using electronic health records) and the design of future metabolic phenotyping studies. |
Collaborator Contribution | ELGH works with a large international consortium (including academic and industry partners) involved in many of its activities. I am working particularly with a UK-wide consortium of diabetes researchers in recall-by-genotype studies based on rare diabetes and obesity-associated variants. |
Impact | Currently this is work in progress and we are in the recruitment phase to recall-by-genotype studies. We have a broad range of multidisciplinary partnerships involved in our community engagement and outreach activities, including close work with community-based organisations (e.g. https://www.safh.org.uk) and engagement workshops involving anthropologists and experts in public engagement (https://www.centreofthecell.org). |
Start Year | 2017 |
Description | East London Genes and Health (ELGH) |
Organisation | University of Exeter |
Department | Medical School |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | I am deputy lead for this large community genomics study. I contribute towards the overall running of this important study (including recruitment, study design and management, recall-by-genotype, community engagement) which is a large community genomics project of British Bangladeshis and Pakistanis (n=28,000). I am also the local PI for a UK consortium studying type 2 diabetes in this cohort, including running recall-by-genotype studies, analysis of big data (using electronic health records) and the design of future metabolic phenotyping studies. |
Collaborator Contribution | ELGH works with a large international consortium (including academic and industry partners) involved in many of its activities. I am working particularly with a UK-wide consortium of diabetes researchers in recall-by-genotype studies based on rare diabetes and obesity-associated variants. |
Impact | Currently this is work in progress and we are in the recruitment phase to recall-by-genotype studies. We have a broad range of multidisciplinary partnerships involved in our community engagement and outreach activities, including close work with community-based organisations (e.g. https://www.safh.org.uk) and engagement workshops involving anthropologists and experts in public engagement (https://www.centreofthecell.org). |
Start Year | 2017 |
Description | East London Genes and Health (ELGH) |
Organisation | University of Oxford |
Department | Oxford Centre for Diabetes Endocrinology and Metabolism (OCDEM) |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | I am deputy lead for this large community genomics study. I contribute towards the overall running of this important study (including recruitment, study design and management, recall-by-genotype, community engagement) which is a large community genomics project of British Bangladeshis and Pakistanis (n=28,000). I am also the local PI for a UK consortium studying type 2 diabetes in this cohort, including running recall-by-genotype studies, analysis of big data (using electronic health records) and the design of future metabolic phenotyping studies. |
Collaborator Contribution | ELGH works with a large international consortium (including academic and industry partners) involved in many of its activities. I am working particularly with a UK-wide consortium of diabetes researchers in recall-by-genotype studies based on rare diabetes and obesity-associated variants. |
Impact | Currently this is work in progress and we are in the recruitment phase to recall-by-genotype studies. We have a broad range of multidisciplinary partnerships involved in our community engagement and outreach activities, including close work with community-based organisations (e.g. https://www.safh.org.uk) and engagement workshops involving anthropologists and experts in public engagement (https://www.centreofthecell.org). |
Start Year | 2017 |
Description | Education data sharing |
Organisation | Department for Education |
Country | United Kingdom |
Sector | Public |
PI Contribution | We are linking health and education data to allow the Department for Education to better understand the health barriers to learning experienced by children and young people. |
Collaborator Contribution | The Department for Education have provided us with the education records of children across the whole of our District for the past 10 years |
Impact | We now have the UK's only database of linked education and health records |
Start Year | 2021 |
Description | Genes & Health metabolic research consortium |
Organisation | Council of Scientific and Industrial Research (CSIR) |
Department | Centre for Cellular and Molecular Biology (CCMB) |
Country | India |
Sector | Academic/University |
PI Contribution | I lead a large interdisciplinary research programme, embedded in Genes & Health, that is using interdisciplinary methods to better understand the role of genetics on metabolic health in British south Asians. This work spans rare variant gene discovery (collaborating with Prof Sir Steve O'Rahilly's team in Cambridge) and the generation of ancestry-specific polygenic risk scores for for clinical application. |
Collaborator Contribution | University of Cambridge (Prof Sir Steve O'Rahilly) - rare gene variant discovery, functional characterisation and validation in population based cohorts University of Exeter (Richard Oram, Mike Weedon) - construction and testing of type 1 diabetes polygenic risk scores and its application to studies of diabetes misclassification London School of Hygiene and Tropical Medicine (Rohini Mathur) - advanced epidemiological analysis of real world data in British south Asians Wellcome Trust Sanger Institute (Hilary Martin) - construction and testing of polygenic risks scores KEM Hospital Pune (Ranjan Yajnik) - reference/validation south Asian populations and understanding of phenotype-genotype correlation CSIR (Giriraj Chandak) - GWAS and polygenic risk score generation in south Asian populations |
Impact | 1. Lam BYH*, Williamson A*, Finer S*(*joint first authors), Day F, Tadross JA,Gonçalves Soares A, Wade K, Sweeney P, Bedenbaugh MN, Porter DT, Melvin A, Ellacott KLJ, Lippert RN, Buller S, Rosmaninho-Salgado J, Dowsett GKC, Ridley KE, Xu Z, Cimino I, Rimmington D, Rainbow K, Duckett K, Holmqvist S, Khan A, Dai X, Bochukova EG, Genes & Health Research Team, Trembath RC, Martin HC, Coll AP, Rowitch DH, Wareham NJ, van Heel DA, Timpson N, Simerly RB, Ong KK, Cone, RD, Langenberg C*, Perry JRB*, Yeo GS*, O'Rahilly S*. (2021). MC3R links nutritional state to childhood growth and the timing of puberty. Nature, in press (2020-12-22599D) 2. Mathur R, Hull SA, Hodgson S, Finer S (2021). Characterisation of type 2 diabetes subgroups and their association with ethnicity and clinical outcomes: a UK real-world data study using the East London Database. British Journal of General Practice. 2022 Feb. https://doi.org/10.3399/BJGP.2021.0508 3. Pervjakova N, Moen GH, Borges MC, Ferreira T, Cook JP, Allard C, Beaumont RN, Canouil M, Hatem G, Heiskala A, Joensuu A, Karhunen V, Kwak SH, Lin FTJ, Liu J, Rifas-Shiman S, Tam CH, Tam WH, Thorleifsson G, Andrew T, Auvinen J, Bhowmik B, Bonnefond A, Delahaye F, Demirkan A, Froguel P, Haller-Kikkatalo K, Hardardottir H, Hummel S, Hussain A, Kajantie E, Keikkala E, Khamis A, Lahti J, Lekva T, Mustaniemi S, Sommer C, Tagoma A, Tzala E, Uibo R, Vääräsmäki M, Villa PM, Birkeland KI, Bouchard L, Duijn CM, Finer S, Groop L, Hämäläinen E, Hayes GM, Hitman GA, Jang HC, Järvelin MR, Jenum AK, Laivuori H, Ma RC, Melander O, Oken E, Park KS, Perron P, Prasad RB, Qvigstad E, Sebert S, Stefansson K, Steinthorsdottir V, Tuomi T, Hivert MF, Franks PW, McCarthy MI, Lindgren CM, Freathy RM, Lawlor DA, Morris AP, Mägi R. Multi-ancestry genome-wide association study of gestational diabetes mellitus highlights genetic links with type 2 diabetes. Hum Mol Genet. 2022 Feb 26: Epub ahead of print. PMID: 35220425. 4. Nongmaithem SS, Beaumont RN, Dedaniya A, Wood AR, Ogunkolade BW, Hassan Z, Krishnaveni GV, Kumaran K, Potdar RD, Sahariah SA, Krishna M, Di Gravio C, Mali ID, Sankareswaran A, Hussain A, Bhowmik BW, Khan AKA, Knight BA, Frayling TM, Finer S, Fall CH, Yajnik CS, Freathy RM, Hitman GA, Chandak GR. Babies of South Asian and European Ancestry Show Similar Associations with Genetic Risk Score for Birth Weight Despite the Smaller Size of South Asian Newborns. Diabetes. 2022 Jan. Epub ahead of print. PMID: 35061033. 5. Hodgson S, Huang Q, Sallah N, Genes & Health Research Team, Griffiths CG, Newman WG, Trembath RC, Lumbers T, Kuchenbaecker K, van Heel DA, Mathur R, Martin H, Finer S (2021) Harnessing the power of polygenic risk scores to predict type 2 diabetes and its subtypes in a high-risk population of British Pakistanis and Bangladeshis in a routine healthcare setting. MedRxiv Preprint (under review with PLoS Medicine) https://www.medrxiv.org/content/10.1101/2021.07.12.21259837v1.full.pdf. |
Start Year | 2020 |
Description | Genes & Health metabolic research consortium |
Organisation | KEM Hospital, Pune |
Country | India |
Sector | Hospitals |
PI Contribution | I lead a large interdisciplinary research programme, embedded in Genes & Health, that is using interdisciplinary methods to better understand the role of genetics on metabolic health in British south Asians. This work spans rare variant gene discovery (collaborating with Prof Sir Steve O'Rahilly's team in Cambridge) and the generation of ancestry-specific polygenic risk scores for for clinical application. |
Collaborator Contribution | University of Cambridge (Prof Sir Steve O'Rahilly) - rare gene variant discovery, functional characterisation and validation in population based cohorts University of Exeter (Richard Oram, Mike Weedon) - construction and testing of type 1 diabetes polygenic risk scores and its application to studies of diabetes misclassification London School of Hygiene and Tropical Medicine (Rohini Mathur) - advanced epidemiological analysis of real world data in British south Asians Wellcome Trust Sanger Institute (Hilary Martin) - construction and testing of polygenic risks scores KEM Hospital Pune (Ranjan Yajnik) - reference/validation south Asian populations and understanding of phenotype-genotype correlation CSIR (Giriraj Chandak) - GWAS and polygenic risk score generation in south Asian populations |
Impact | 1. Lam BYH*, Williamson A*, Finer S*(*joint first authors), Day F, Tadross JA,Gonçalves Soares A, Wade K, Sweeney P, Bedenbaugh MN, Porter DT, Melvin A, Ellacott KLJ, Lippert RN, Buller S, Rosmaninho-Salgado J, Dowsett GKC, Ridley KE, Xu Z, Cimino I, Rimmington D, Rainbow K, Duckett K, Holmqvist S, Khan A, Dai X, Bochukova EG, Genes & Health Research Team, Trembath RC, Martin HC, Coll AP, Rowitch DH, Wareham NJ, van Heel DA, Timpson N, Simerly RB, Ong KK, Cone, RD, Langenberg C*, Perry JRB*, Yeo GS*, O'Rahilly S*. (2021). MC3R links nutritional state to childhood growth and the timing of puberty. Nature, in press (2020-12-22599D) 2. Mathur R, Hull SA, Hodgson S, Finer S (2021). Characterisation of type 2 diabetes subgroups and their association with ethnicity and clinical outcomes: a UK real-world data study using the East London Database. British Journal of General Practice. 2022 Feb. https://doi.org/10.3399/BJGP.2021.0508 3. Pervjakova N, Moen GH, Borges MC, Ferreira T, Cook JP, Allard C, Beaumont RN, Canouil M, Hatem G, Heiskala A, Joensuu A, Karhunen V, Kwak SH, Lin FTJ, Liu J, Rifas-Shiman S, Tam CH, Tam WH, Thorleifsson G, Andrew T, Auvinen J, Bhowmik B, Bonnefond A, Delahaye F, Demirkan A, Froguel P, Haller-Kikkatalo K, Hardardottir H, Hummel S, Hussain A, Kajantie E, Keikkala E, Khamis A, Lahti J, Lekva T, Mustaniemi S, Sommer C, Tagoma A, Tzala E, Uibo R, Vääräsmäki M, Villa PM, Birkeland KI, Bouchard L, Duijn CM, Finer S, Groop L, Hämäläinen E, Hayes GM, Hitman GA, Jang HC, Järvelin MR, Jenum AK, Laivuori H, Ma RC, Melander O, Oken E, Park KS, Perron P, Prasad RB, Qvigstad E, Sebert S, Stefansson K, Steinthorsdottir V, Tuomi T, Hivert MF, Franks PW, McCarthy MI, Lindgren CM, Freathy RM, Lawlor DA, Morris AP, Mägi R. Multi-ancestry genome-wide association study of gestational diabetes mellitus highlights genetic links with type 2 diabetes. Hum Mol Genet. 2022 Feb 26: Epub ahead of print. PMID: 35220425. 4. Nongmaithem SS, Beaumont RN, Dedaniya A, Wood AR, Ogunkolade BW, Hassan Z, Krishnaveni GV, Kumaran K, Potdar RD, Sahariah SA, Krishna M, Di Gravio C, Mali ID, Sankareswaran A, Hussain A, Bhowmik BW, Khan AKA, Knight BA, Frayling TM, Finer S, Fall CH, Yajnik CS, Freathy RM, Hitman GA, Chandak GR. Babies of South Asian and European Ancestry Show Similar Associations with Genetic Risk Score for Birth Weight Despite the Smaller Size of South Asian Newborns. Diabetes. 2022 Jan. Epub ahead of print. PMID: 35061033. 5. Hodgson S, Huang Q, Sallah N, Genes & Health Research Team, Griffiths CG, Newman WG, Trembath RC, Lumbers T, Kuchenbaecker K, van Heel DA, Mathur R, Martin H, Finer S (2021) Harnessing the power of polygenic risk scores to predict type 2 diabetes and its subtypes in a high-risk population of British Pakistanis and Bangladeshis in a routine healthcare setting. MedRxiv Preprint (under review with PLoS Medicine) https://www.medrxiv.org/content/10.1101/2021.07.12.21259837v1.full.pdf. |
Start Year | 2020 |
Description | Genes & Health metabolic research consortium |
Organisation | London School of Hygiene and Tropical Medicine (LSHTM) |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | I lead a large interdisciplinary research programme, embedded in Genes & Health, that is using interdisciplinary methods to better understand the role of genetics on metabolic health in British south Asians. This work spans rare variant gene discovery (collaborating with Prof Sir Steve O'Rahilly's team in Cambridge) and the generation of ancestry-specific polygenic risk scores for for clinical application. |
Collaborator Contribution | University of Cambridge (Prof Sir Steve O'Rahilly) - rare gene variant discovery, functional characterisation and validation in population based cohorts University of Exeter (Richard Oram, Mike Weedon) - construction and testing of type 1 diabetes polygenic risk scores and its application to studies of diabetes misclassification London School of Hygiene and Tropical Medicine (Rohini Mathur) - advanced epidemiological analysis of real world data in British south Asians Wellcome Trust Sanger Institute (Hilary Martin) - construction and testing of polygenic risks scores KEM Hospital Pune (Ranjan Yajnik) - reference/validation south Asian populations and understanding of phenotype-genotype correlation CSIR (Giriraj Chandak) - GWAS and polygenic risk score generation in south Asian populations |
Impact | 1. Lam BYH*, Williamson A*, Finer S*(*joint first authors), Day F, Tadross JA,Gonçalves Soares A, Wade K, Sweeney P, Bedenbaugh MN, Porter DT, Melvin A, Ellacott KLJ, Lippert RN, Buller S, Rosmaninho-Salgado J, Dowsett GKC, Ridley KE, Xu Z, Cimino I, Rimmington D, Rainbow K, Duckett K, Holmqvist S, Khan A, Dai X, Bochukova EG, Genes & Health Research Team, Trembath RC, Martin HC, Coll AP, Rowitch DH, Wareham NJ, van Heel DA, Timpson N, Simerly RB, Ong KK, Cone, RD, Langenberg C*, Perry JRB*, Yeo GS*, O'Rahilly S*. (2021). MC3R links nutritional state to childhood growth and the timing of puberty. Nature, in press (2020-12-22599D) 2. Mathur R, Hull SA, Hodgson S, Finer S (2021). Characterisation of type 2 diabetes subgroups and their association with ethnicity and clinical outcomes: a UK real-world data study using the East London Database. British Journal of General Practice. 2022 Feb. https://doi.org/10.3399/BJGP.2021.0508 3. Pervjakova N, Moen GH, Borges MC, Ferreira T, Cook JP, Allard C, Beaumont RN, Canouil M, Hatem G, Heiskala A, Joensuu A, Karhunen V, Kwak SH, Lin FTJ, Liu J, Rifas-Shiman S, Tam CH, Tam WH, Thorleifsson G, Andrew T, Auvinen J, Bhowmik B, Bonnefond A, Delahaye F, Demirkan A, Froguel P, Haller-Kikkatalo K, Hardardottir H, Hummel S, Hussain A, Kajantie E, Keikkala E, Khamis A, Lahti J, Lekva T, Mustaniemi S, Sommer C, Tagoma A, Tzala E, Uibo R, Vääräsmäki M, Villa PM, Birkeland KI, Bouchard L, Duijn CM, Finer S, Groop L, Hämäläinen E, Hayes GM, Hitman GA, Jang HC, Järvelin MR, Jenum AK, Laivuori H, Ma RC, Melander O, Oken E, Park KS, Perron P, Prasad RB, Qvigstad E, Sebert S, Stefansson K, Steinthorsdottir V, Tuomi T, Hivert MF, Franks PW, McCarthy MI, Lindgren CM, Freathy RM, Lawlor DA, Morris AP, Mägi R. Multi-ancestry genome-wide association study of gestational diabetes mellitus highlights genetic links with type 2 diabetes. Hum Mol Genet. 2022 Feb 26: Epub ahead of print. PMID: 35220425. 4. Nongmaithem SS, Beaumont RN, Dedaniya A, Wood AR, Ogunkolade BW, Hassan Z, Krishnaveni GV, Kumaran K, Potdar RD, Sahariah SA, Krishna M, Di Gravio C, Mali ID, Sankareswaran A, Hussain A, Bhowmik BW, Khan AKA, Knight BA, Frayling TM, Finer S, Fall CH, Yajnik CS, Freathy RM, Hitman GA, Chandak GR. Babies of South Asian and European Ancestry Show Similar Associations with Genetic Risk Score for Birth Weight Despite the Smaller Size of South Asian Newborns. Diabetes. 2022 Jan. Epub ahead of print. PMID: 35061033. 5. Hodgson S, Huang Q, Sallah N, Genes & Health Research Team, Griffiths CG, Newman WG, Trembath RC, Lumbers T, Kuchenbaecker K, van Heel DA, Mathur R, Martin H, Finer S (2021) Harnessing the power of polygenic risk scores to predict type 2 diabetes and its subtypes in a high-risk population of British Pakistanis and Bangladeshis in a routine healthcare setting. MedRxiv Preprint (under review with PLoS Medicine) https://www.medrxiv.org/content/10.1101/2021.07.12.21259837v1.full.pdf. |
Start Year | 2020 |
Description | Genes & Health metabolic research consortium |
Organisation | The Wellcome Trust Sanger Institute |
Country | United Kingdom |
Sector | Charity/Non Profit |
PI Contribution | I lead a large interdisciplinary research programme, embedded in Genes & Health, that is using interdisciplinary methods to better understand the role of genetics on metabolic health in British south Asians. This work spans rare variant gene discovery (collaborating with Prof Sir Steve O'Rahilly's team in Cambridge) and the generation of ancestry-specific polygenic risk scores for for clinical application. |
Collaborator Contribution | University of Cambridge (Prof Sir Steve O'Rahilly) - rare gene variant discovery, functional characterisation and validation in population based cohorts University of Exeter (Richard Oram, Mike Weedon) - construction and testing of type 1 diabetes polygenic risk scores and its application to studies of diabetes misclassification London School of Hygiene and Tropical Medicine (Rohini Mathur) - advanced epidemiological analysis of real world data in British south Asians Wellcome Trust Sanger Institute (Hilary Martin) - construction and testing of polygenic risks scores KEM Hospital Pune (Ranjan Yajnik) - reference/validation south Asian populations and understanding of phenotype-genotype correlation CSIR (Giriraj Chandak) - GWAS and polygenic risk score generation in south Asian populations |
Impact | 1. Lam BYH*, Williamson A*, Finer S*(*joint first authors), Day F, Tadross JA,Gonçalves Soares A, Wade K, Sweeney P, Bedenbaugh MN, Porter DT, Melvin A, Ellacott KLJ, Lippert RN, Buller S, Rosmaninho-Salgado J, Dowsett GKC, Ridley KE, Xu Z, Cimino I, Rimmington D, Rainbow K, Duckett K, Holmqvist S, Khan A, Dai X, Bochukova EG, Genes & Health Research Team, Trembath RC, Martin HC, Coll AP, Rowitch DH, Wareham NJ, van Heel DA, Timpson N, Simerly RB, Ong KK, Cone, RD, Langenberg C*, Perry JRB*, Yeo GS*, O'Rahilly S*. (2021). MC3R links nutritional state to childhood growth and the timing of puberty. Nature, in press (2020-12-22599D) 2. Mathur R, Hull SA, Hodgson S, Finer S (2021). Characterisation of type 2 diabetes subgroups and their association with ethnicity and clinical outcomes: a UK real-world data study using the East London Database. British Journal of General Practice. 2022 Feb. https://doi.org/10.3399/BJGP.2021.0508 3. Pervjakova N, Moen GH, Borges MC, Ferreira T, Cook JP, Allard C, Beaumont RN, Canouil M, Hatem G, Heiskala A, Joensuu A, Karhunen V, Kwak SH, Lin FTJ, Liu J, Rifas-Shiman S, Tam CH, Tam WH, Thorleifsson G, Andrew T, Auvinen J, Bhowmik B, Bonnefond A, Delahaye F, Demirkan A, Froguel P, Haller-Kikkatalo K, Hardardottir H, Hummel S, Hussain A, Kajantie E, Keikkala E, Khamis A, Lahti J, Lekva T, Mustaniemi S, Sommer C, Tagoma A, Tzala E, Uibo R, Vääräsmäki M, Villa PM, Birkeland KI, Bouchard L, Duijn CM, Finer S, Groop L, Hämäläinen E, Hayes GM, Hitman GA, Jang HC, Järvelin MR, Jenum AK, Laivuori H, Ma RC, Melander O, Oken E, Park KS, Perron P, Prasad RB, Qvigstad E, Sebert S, Stefansson K, Steinthorsdottir V, Tuomi T, Hivert MF, Franks PW, McCarthy MI, Lindgren CM, Freathy RM, Lawlor DA, Morris AP, Mägi R. Multi-ancestry genome-wide association study of gestational diabetes mellitus highlights genetic links with type 2 diabetes. Hum Mol Genet. 2022 Feb 26: Epub ahead of print. PMID: 35220425. 4. Nongmaithem SS, Beaumont RN, Dedaniya A, Wood AR, Ogunkolade BW, Hassan Z, Krishnaveni GV, Kumaran K, Potdar RD, Sahariah SA, Krishna M, Di Gravio C, Mali ID, Sankareswaran A, Hussain A, Bhowmik BW, Khan AKA, Knight BA, Frayling TM, Finer S, Fall CH, Yajnik CS, Freathy RM, Hitman GA, Chandak GR. Babies of South Asian and European Ancestry Show Similar Associations with Genetic Risk Score for Birth Weight Despite the Smaller Size of South Asian Newborns. Diabetes. 2022 Jan. Epub ahead of print. PMID: 35061033. 5. Hodgson S, Huang Q, Sallah N, Genes & Health Research Team, Griffiths CG, Newman WG, Trembath RC, Lumbers T, Kuchenbaecker K, van Heel DA, Mathur R, Martin H, Finer S (2021) Harnessing the power of polygenic risk scores to predict type 2 diabetes and its subtypes in a high-risk population of British Pakistanis and Bangladeshis in a routine healthcare setting. MedRxiv Preprint (under review with PLoS Medicine) https://www.medrxiv.org/content/10.1101/2021.07.12.21259837v1.full.pdf. |
Start Year | 2020 |
Description | Genes & Health metabolic research consortium |
Organisation | University of Cambridge |
Department | Metabolic Research Laboratories |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | I lead a large interdisciplinary research programme, embedded in Genes & Health, that is using interdisciplinary methods to better understand the role of genetics on metabolic health in British south Asians. This work spans rare variant gene discovery (collaborating with Prof Sir Steve O'Rahilly's team in Cambridge) and the generation of ancestry-specific polygenic risk scores for for clinical application. |
Collaborator Contribution | University of Cambridge (Prof Sir Steve O'Rahilly) - rare gene variant discovery, functional characterisation and validation in population based cohorts University of Exeter (Richard Oram, Mike Weedon) - construction and testing of type 1 diabetes polygenic risk scores and its application to studies of diabetes misclassification London School of Hygiene and Tropical Medicine (Rohini Mathur) - advanced epidemiological analysis of real world data in British south Asians Wellcome Trust Sanger Institute (Hilary Martin) - construction and testing of polygenic risks scores KEM Hospital Pune (Ranjan Yajnik) - reference/validation south Asian populations and understanding of phenotype-genotype correlation CSIR (Giriraj Chandak) - GWAS and polygenic risk score generation in south Asian populations |
Impact | 1. Lam BYH*, Williamson A*, Finer S*(*joint first authors), Day F, Tadross JA,Gonçalves Soares A, Wade K, Sweeney P, Bedenbaugh MN, Porter DT, Melvin A, Ellacott KLJ, Lippert RN, Buller S, Rosmaninho-Salgado J, Dowsett GKC, Ridley KE, Xu Z, Cimino I, Rimmington D, Rainbow K, Duckett K, Holmqvist S, Khan A, Dai X, Bochukova EG, Genes & Health Research Team, Trembath RC, Martin HC, Coll AP, Rowitch DH, Wareham NJ, van Heel DA, Timpson N, Simerly RB, Ong KK, Cone, RD, Langenberg C*, Perry JRB*, Yeo GS*, O'Rahilly S*. (2021). MC3R links nutritional state to childhood growth and the timing of puberty. Nature, in press (2020-12-22599D) 2. Mathur R, Hull SA, Hodgson S, Finer S (2021). Characterisation of type 2 diabetes subgroups and their association with ethnicity and clinical outcomes: a UK real-world data study using the East London Database. British Journal of General Practice. 2022 Feb. https://doi.org/10.3399/BJGP.2021.0508 3. Pervjakova N, Moen GH, Borges MC, Ferreira T, Cook JP, Allard C, Beaumont RN, Canouil M, Hatem G, Heiskala A, Joensuu A, Karhunen V, Kwak SH, Lin FTJ, Liu J, Rifas-Shiman S, Tam CH, Tam WH, Thorleifsson G, Andrew T, Auvinen J, Bhowmik B, Bonnefond A, Delahaye F, Demirkan A, Froguel P, Haller-Kikkatalo K, Hardardottir H, Hummel S, Hussain A, Kajantie E, Keikkala E, Khamis A, Lahti J, Lekva T, Mustaniemi S, Sommer C, Tagoma A, Tzala E, Uibo R, Vääräsmäki M, Villa PM, Birkeland KI, Bouchard L, Duijn CM, Finer S, Groop L, Hämäläinen E, Hayes GM, Hitman GA, Jang HC, Järvelin MR, Jenum AK, Laivuori H, Ma RC, Melander O, Oken E, Park KS, Perron P, Prasad RB, Qvigstad E, Sebert S, Stefansson K, Steinthorsdottir V, Tuomi T, Hivert MF, Franks PW, McCarthy MI, Lindgren CM, Freathy RM, Lawlor DA, Morris AP, Mägi R. Multi-ancestry genome-wide association study of gestational diabetes mellitus highlights genetic links with type 2 diabetes. Hum Mol Genet. 2022 Feb 26: Epub ahead of print. PMID: 35220425. 4. Nongmaithem SS, Beaumont RN, Dedaniya A, Wood AR, Ogunkolade BW, Hassan Z, Krishnaveni GV, Kumaran K, Potdar RD, Sahariah SA, Krishna M, Di Gravio C, Mali ID, Sankareswaran A, Hussain A, Bhowmik BW, Khan AKA, Knight BA, Frayling TM, Finer S, Fall CH, Yajnik CS, Freathy RM, Hitman GA, Chandak GR. Babies of South Asian and European Ancestry Show Similar Associations with Genetic Risk Score for Birth Weight Despite the Smaller Size of South Asian Newborns. Diabetes. 2022 Jan. Epub ahead of print. PMID: 35061033. 5. Hodgson S, Huang Q, Sallah N, Genes & Health Research Team, Griffiths CG, Newman WG, Trembath RC, Lumbers T, Kuchenbaecker K, van Heel DA, Mathur R, Martin H, Finer S (2021) Harnessing the power of polygenic risk scores to predict type 2 diabetes and its subtypes in a high-risk population of British Pakistanis and Bangladeshis in a routine healthcare setting. MedRxiv Preprint (under review with PLoS Medicine) https://www.medrxiv.org/content/10.1101/2021.07.12.21259837v1.full.pdf. |
Start Year | 2020 |
Description | Genes & Health metabolic research consortium |
Organisation | University of Exeter |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | I lead a large interdisciplinary research programme, embedded in Genes & Health, that is using interdisciplinary methods to better understand the role of genetics on metabolic health in British south Asians. This work spans rare variant gene discovery (collaborating with Prof Sir Steve O'Rahilly's team in Cambridge) and the generation of ancestry-specific polygenic risk scores for for clinical application. |
Collaborator Contribution | University of Cambridge (Prof Sir Steve O'Rahilly) - rare gene variant discovery, functional characterisation and validation in population based cohorts University of Exeter (Richard Oram, Mike Weedon) - construction and testing of type 1 diabetes polygenic risk scores and its application to studies of diabetes misclassification London School of Hygiene and Tropical Medicine (Rohini Mathur) - advanced epidemiological analysis of real world data in British south Asians Wellcome Trust Sanger Institute (Hilary Martin) - construction and testing of polygenic risks scores KEM Hospital Pune (Ranjan Yajnik) - reference/validation south Asian populations and understanding of phenotype-genotype correlation CSIR (Giriraj Chandak) - GWAS and polygenic risk score generation in south Asian populations |
Impact | 1. Lam BYH*, Williamson A*, Finer S*(*joint first authors), Day F, Tadross JA,Gonçalves Soares A, Wade K, Sweeney P, Bedenbaugh MN, Porter DT, Melvin A, Ellacott KLJ, Lippert RN, Buller S, Rosmaninho-Salgado J, Dowsett GKC, Ridley KE, Xu Z, Cimino I, Rimmington D, Rainbow K, Duckett K, Holmqvist S, Khan A, Dai X, Bochukova EG, Genes & Health Research Team, Trembath RC, Martin HC, Coll AP, Rowitch DH, Wareham NJ, van Heel DA, Timpson N, Simerly RB, Ong KK, Cone, RD, Langenberg C*, Perry JRB*, Yeo GS*, O'Rahilly S*. (2021). MC3R links nutritional state to childhood growth and the timing of puberty. Nature, in press (2020-12-22599D) 2. Mathur R, Hull SA, Hodgson S, Finer S (2021). Characterisation of type 2 diabetes subgroups and their association with ethnicity and clinical outcomes: a UK real-world data study using the East London Database. British Journal of General Practice. 2022 Feb. https://doi.org/10.3399/BJGP.2021.0508 3. Pervjakova N, Moen GH, Borges MC, Ferreira T, Cook JP, Allard C, Beaumont RN, Canouil M, Hatem G, Heiskala A, Joensuu A, Karhunen V, Kwak SH, Lin FTJ, Liu J, Rifas-Shiman S, Tam CH, Tam WH, Thorleifsson G, Andrew T, Auvinen J, Bhowmik B, Bonnefond A, Delahaye F, Demirkan A, Froguel P, Haller-Kikkatalo K, Hardardottir H, Hummel S, Hussain A, Kajantie E, Keikkala E, Khamis A, Lahti J, Lekva T, Mustaniemi S, Sommer C, Tagoma A, Tzala E, Uibo R, Vääräsmäki M, Villa PM, Birkeland KI, Bouchard L, Duijn CM, Finer S, Groop L, Hämäläinen E, Hayes GM, Hitman GA, Jang HC, Järvelin MR, Jenum AK, Laivuori H, Ma RC, Melander O, Oken E, Park KS, Perron P, Prasad RB, Qvigstad E, Sebert S, Stefansson K, Steinthorsdottir V, Tuomi T, Hivert MF, Franks PW, McCarthy MI, Lindgren CM, Freathy RM, Lawlor DA, Morris AP, Mägi R. Multi-ancestry genome-wide association study of gestational diabetes mellitus highlights genetic links with type 2 diabetes. Hum Mol Genet. 2022 Feb 26: Epub ahead of print. PMID: 35220425. 4. Nongmaithem SS, Beaumont RN, Dedaniya A, Wood AR, Ogunkolade BW, Hassan Z, Krishnaveni GV, Kumaran K, Potdar RD, Sahariah SA, Krishna M, Di Gravio C, Mali ID, Sankareswaran A, Hussain A, Bhowmik BW, Khan AKA, Knight BA, Frayling TM, Finer S, Fall CH, Yajnik CS, Freathy RM, Hitman GA, Chandak GR. Babies of South Asian and European Ancestry Show Similar Associations with Genetic Risk Score for Birth Weight Despite the Smaller Size of South Asian Newborns. Diabetes. 2022 Jan. Epub ahead of print. PMID: 35061033. 5. Hodgson S, Huang Q, Sallah N, Genes & Health Research Team, Griffiths CG, Newman WG, Trembath RC, Lumbers T, Kuchenbaecker K, van Heel DA, Mathur R, Martin H, Finer S (2021) Harnessing the power of polygenic risk scores to predict type 2 diabetes and its subtypes in a high-risk population of British Pakistanis and Bangladeshis in a routine healthcare setting. MedRxiv Preprint (under review with PLoS Medicine) https://www.medrxiv.org/content/10.1101/2021.07.12.21259837v1.full.pdf. |
Start Year | 2020 |
Description | Genes 2 Mental Health Network (G2MH) |
Organisation | National Institutes of Health (NIH) |
Department | National Institute of Mental Health (NIMH) |
Country | United States |
Sector | Public |
PI Contribution | Increased awareness of the rick of physical and mental health multimorbidity in people with Copy Number Variation. |
Collaborator Contribution | Opportunities for collaboration with a large NIMH-led network of international researchers studying rare genetic variation and mental health. The G2MH network also offers opportunities for replication of our findings in a large international data set. |
Impact | As above |
Start Year | 2019 |
Description | Genes and Health (G&H) Study |
Organisation | East London Genes and Health |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Enhanced links between research institutions: Cardiff University, Leeds University, Bristol University, Copenhagen University, Exeter University, Wellcome Sanger Institute. Enhanced links between research cohorts Avon Longitudinal Study of Parents and Children (ALSPAC), Born in Bradford (BiB) and Danish Integrative Psychiatric Research (iPSYCH) studies. |
Collaborator Contribution | The G&H cohort is one of the five research cohorts our Research Collaborative will conduct research in. G&H/ Queen Mary University London researchers have made significant contributions to the development of our Research Collaborative grant proposal. |
Impact | Collaborative grant proposal submitted. |
Start Year | 2020 |
Description | Intellectual Disability and Mental Health: Assessing Genomic Impact on Neurodevelopment (IMAGINE) |
Organisation | University College London |
Department | Institute of Child Health |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | I am an IMAGINE-ID co-investigator, leading the face-to-face phenotyping WP (WP2) of this grant. Insights we gained whilst developing our Research Collaborative proposal have been shared with the IMAGINE-ID team during our investigator meetings. |
Collaborator Contribution | The IMAGINE-ID team follows young people with genetic conditions linked intellectual disability over time. The insights IMAGINE-ID is generating on these young people's longitudinal development has impacted on our planning of the Research Collaborative project. |
Impact | The links with the NHS, charities, politicians we have developed as part of IMAGINE-ID are benefitting our Research Collaborative. The collaboration is multidisciplinary, involving mental health, physical health, epidemiology, genetics. |
Start Year | 2014 |
Description | International consortium for the study of early life multimorbidity using registry-linked cohort data (EMERGENT project) |
Organisation | Norwegian Institute of Public Health |
Country | Norway |
Sector | Public |
PI Contribution | Mutual exchange of ideas and plans to enhance the research both sites are conducting into multimorbidity |
Collaborator Contribution | Mutual exchange of ideas and plans to enhance the research both sites are conducting into multimorbidity |
Impact | Attendance of brainstorming meeting with the EMERGENT research team in Oslo, Norway, to plan together the start of the EMERGENT project. |
Start Year | 2024 |
Description | MHCLG partnership on use of data to take a place based approach to service delivery |
Organisation | Ministry of Housing, Communities and Local Government |
Country | United Kingdom |
Sector | Public |
PI Contribution | 1. Interrogated, mapped, modelled and helped better understand future service demands and the interactions with other public service providers in managing shifting and emergent vulnerabilities. 2. Helping to improve understanding and shape how public sector agencies and partners can effectively respond to and prevent future threat, harm and vulnerability through integrated multi-sectorial partnerships. |
Collaborator Contribution | Provided funding for community engagement team. More generally, helped establish a wider network of public services and technological provision, and use of practice-based implementation, innovation and experimentation to effect national and international change through linking the research with the work in the People, Places & Communities Team at MHCLG. |
Impact | The partnership has enabled an exciting, new conversation about implementing change across public sector organisations and how they work effectively across disciplinary and professional silos to enhance preventive capabilities. |
Start Year | 2021 |
Description | MHCLG partnership on use of data to take a place based approach to service delivery |
Organisation | Ministry of Housing, Communities and Local Government |
Country | United Kingdom |
Sector | Public |
PI Contribution | 1. Interrogated, mapped, modelled and helped better understand future service demands and the interactions with other public service providers in managing shifting and emergent vulnerabilities. 2. Helping to improve understanding and shape how public sector agencies and partners can effectively respond to and prevent future threat, harm and vulnerability through integrated multi-sectorial partnerships. |
Collaborator Contribution | Provided funding for community engagement team. More generally, helped establish a wider network of public services and technological provision, and use of practice-based implementation, innovation and experimentation to effect national and international change through linking the research with the work in the People, Places & Communities Team at MHCLG. |
Impact | The partnership has enabled an exciting, new conversation about implementing change across public sector organisations and how they work effectively across disciplinary and professional silos to enhance preventive capabilities. |
Start Year | 2021 |
Description | MLTC-M Community of Practice in ECR training on best practice patient and public involvement with diverse populations |
Organisation | University of Birmingham |
Department | Institute of Applied Health Research |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Conceptual contribution in developing the idea, plans and recruitment of potential network members to support the grant application to the Medical Research Council in February 2022, including from the LINC collaborative PPI lead (Rupert Payne), PPI coordinator (Julie Clayton) and PPI and impact officer (Lowri O'Donovan), and PPI co-applicants Jane Sprackman and Shahid Khan. Once it was funded, we have all been involved in developing plans for, and delivering, Community of Practice (CoP) activities. |
Collaborator Contribution | University of Birmingham postdoctoral fellow Dr Stephanie Hanley and colleagues are the principal leads for the Community of Practice and have taken responsibility for delivering all CoP activities. |
Impact | Initial face-to-face Community of Practice (CoP) workshop on 22 November 2023 in Birmingham, which brought together PPI contributors, PPI leads and Early Career Researchers (ECRs) from all the MRC-funded multimorbidity collaboratives including 5 postdoctoral fellows and a PhD student from LINC. This was the start of training and resource-building, to develop the PPI knowledge and skills of ECRs and network relationships. This was followed by an online workshop on 27 February 2023 in which we are starting to build plans for future activities, and prioritise goals and objectives for attendees. |
Start Year | 2022 |
Description | MoBa |
Organisation | Norwegian Mother and Child Cohort (MoBa) |
Country | Norway |
Sector | Public |
PI Contribution | We have discussed opportunities for collaboration on physical and mental health multimorbidity. Cardiff has advised MoBa researchers on research measures and ethics applications for studying individuals with rare genetic disorders. |
Collaborator Contribution | MoBA researchers have written letters of support for our Research Collaborative application. If our application is successful, we will work together. This will offer opportunities for future collaborative grant proposals as well as joint research papers. |
Impact | The collaboration is multidisciplinary, involving mental health, physical health, epidemiology, genetics. |
Start Year | 2020 |
Description | NIHR AiM Development Award (NIHR202635) |
Organisation | Newcastle University |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Characterising the dynamic inter-relationships between polypharmacy and multiple long-term conditions. Using artificial intelligence (AI) to map patient journeys into multimorbidity clusters across the UK This is a recently awarded development grant awarded by NIHR, on which I am Co-Investigator. This NIHR grant is integrating with my Multimorbidity clusters, trajectories and genetic risk, in British south Asians award, using common methodology to define conditions for inclusion in a data-driven multimorbidity cluster analysis. The two grants are complementary, and synergistic - the MRC award generating outputs primarily on ethnicity-associated variation and genetic aetiology of multimorbidity, and the NIHR award developing an AI infrastructure to expand the scope of analyses and investigate the complex and dynamic relationship between multimorbidity and polypharmacy. |
Collaborator Contribution | The partnership has led to the successful NIHR award, and is contributing additional datasets (UK Biobank) and methodology (AI). |
Impact | Further grant funding: NIHR. "Using artificial intelligence (AI) to characterize the dynamic inter-relationships between MUltiple Long-term condiTIons and PoLYpharmacy and across diverse UK populations and inform health care pathways (AI-MULTIPLY)". AIM Research Collaboration. NIHR 31672. April 2022-November 2025, £2,971,000. I am Co-Investigator and Work Package Lead |
Start Year | 2021 |
Description | National Centre for Mental Health |
Organisation | National Center for Mental Health (NCMH) |
Country | Philippines |
Sector | Hospitals |
PI Contribution | The NCMH Director is a collaborator on our Research Collaborative grant. Our Collaborative grant will employ a PPI and Impact Officer. This officer will be embedded within NCMH. This will offer new opportunities for NCMH to be able to link in with the PPI and impact efforts of our project as well as the PPI and impact efforts at the various cohorts that are part of our Collaborative (in particularly the Genes and Health (G&H) cohort at Queen Mary University in London; the Avon Longitudinal Study of Parents and Children (ALSPAC) cohort in Bristol University; and the Born in Bradford (BiB) cohort Leeds University. I am a PI within NCMH. |
Collaborator Contribution | We will benefit from the extensive expertise on mental health existing within NCMH. We will benefit from the highly successful, vibrant NCMH outreach and engagement activities. Our PPI and impact Officer will work together with this team at NCMH. We have already received input on our PPI and impact grant sections from NCMH. The NCMH Intervention Development Coordinator has been part of and made very useful contributions to the PPI/ impact meetings we have organized to develop the PPI/ impact strategies for our Research Collaborative. NCMH has also facilitated the discussions that we have had about our Collaborative grant proposal with Health Care Research Wales. NCMH will help us with our outreach activities and ensure we reach wide-ranging audiences with our findings, including through podcasts, Youtube, radio, TV, other media. |
Impact | This is a multidisciplinary collaboration, involving mental health (including intellectual disability), physical health, genetics, PPI, impact. Outputs that have already resulted from this collaboration include input in the Research Collaborative grant proposal, facilitation of links with Welsh Government and opportunities for outreach through the media. |
Start Year | 2017 |
Description | The MINDDS (Maximising Impact of research in Neuro-Developmental DisorderS) COST Pan-EU network. |
Organisation | European Cooperation in Science and Technology (COST) |
Department | COST Action |
Country | Belgium |
Sector | Public |
PI Contribution | I am Executive Committee Member and have been Leader of Working Group 2. I have led workshop on rare genetic conditions and mental health for clinicians and researchers throughout the EU. |
Collaborator Contribution | Our findings on the impact of rare genetic variants on physical and mental health multimorbidity are fed back into MINDDS. |
Impact | Increased awareness of physical and mental health multimorbidity risk in individuals with rare genetic disorders. |
Start Year | 2017 |
Description | Turing AIM (AI for Multiple long-term conditions) Research Support Facility |
Organisation | Alan Turing Institute |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | Scientific and clinical subject knowledge and methodological expertise |
Collaborator Contribution | Methodological expertise |
Impact | Nil yet |
Start Year | 2022 |
Description | Wolfson Centre for Applied Research |
Organisation | Bradford Institute for Health Research (BIHR) |
Department | Born in Bradford |
Country | United Kingdom |
Sector | Public |
PI Contribution | Our Research Collaborative has discussed our plans with the Wolfson Centre for Applied Research and thus increased awareness of the role of childhood risk factors for the development of internalizing disorder and cardiometabolic disorder multimorbidity later in life. |
Collaborator Contribution | The Wolfson Wolfson Centre for Applied Research will contribute to our Research Collaborative expertise in how health inequalities in young people can be reduced and guidance in which early-years interventions which are most effective. |
Impact | This collaboration will provide our Research Collaborative with pathways into clinical impact. The collaboration is multidisciplinary, involving mental health, physical health, epidemiology, genetics. |
Start Year | 2020 |
Description | Wolfson Centre for Young People's Mental Health |
Organisation | Cardiff University |
Department | Wolfson Centre for Young People's Mental Health |
Country | United Kingdom |
Sector | Academic/University |
PI Contribution | The Cardiff Wolfson Centre has an interest in the longitudinal links between internalizing disorder and physical health disorder. We have agreed that we will have shared seminars, so that the Wolfson Centre stays up-to-date about our findings and that our findings can inform their research strategy. We will also have shared statistical workshops and shared dissemination events. |
Collaborator Contribution | The two Cardiff Wolfson PIs are collaborators on our Research Collaborative. They have expertise in the development of depression over time in young people which they will bring to our project. They are developing evidence-based interventions for internalizing disorder for young people and at-risk families. They are also developing school-based programs to promote positive mental health in young people. They will share best practice about these programs with us. We will also have shared statistical workshops and shared dissemination events. |
Impact | The Cardiff Wolfson Centre Directors are collaborators on our Research Collaborative grant proposal. We have discussed common interests together and plan to collaborate. This will be a multidisciplinary collaboration involving mental health, physical health, genetics, epidemiology, intervention. |
Start Year | 2021 |
Description | iPSYCH |
Organisation | The Lundbeck Foundation Initiative for Integrative Psychiatric Research |
Country | Denmark |
Sector | Academic/University |
PI Contribution | Enhanced links between research institutions: Cardiff University, Leeds University, Queen Mary University London, Bristol University, Exeter University, Wellcome Sanger Institute. Enhanced links between research cohorts Genes and Health (G&H); Born in Bradford (BiB) and Avon Longitudinal Study of Parents and Children (ALSPAC). |
Collaborator Contribution | The iPSYCH cohort is one of the five research cohorts our Research Collaborative will conduct research in. iPSYCH/ Copenhagen researchers have made significant contributions to the development of our Research Collaborative grant proposal. |
Impact | Collaborative grant proposal submitted. |
Start Year | 2020 |
Description | Act Early: Holme Wood Community Meals |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Public/other audiences |
Results and Impact | The events bring together community members, data scientists, practitioners and senior policy makers (from local and central government). The events result in new commissioning of services (e.g. health) and the co-production of solutions to problems identified by the community. |
Year(s) Of Engagement Activity | 2021,2022 |
Description | Article in Very well health |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | Media attention about rare genetic disorders and mental health |
Year(s) Of Engagement Activity | 2021 |
URL | https://www.verywellhealth.com/autism-diagnosing-criteria-genetic-conditions-5095503 |
Description | Briefing to DfE and Westminster |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Policymakers/politicians |
Results and Impact | Briefing on children with CNVs in education setting and LINC programme. |
Year(s) Of Engagement Activity | 2021 |
Description | British Society of Immunology seminar series |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | Presentation about physical and mental health multimorbidity and the LINC multimorbidity research programme and the possible role of inflammation in internalizing and cardiometabolic disorder. |
Year(s) Of Engagement Activity | 2022 |
Description | Chairing conference session |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Session at the 'Future MINDDS: Recent advances and future directions for research of Neurodevelopmental Disorders (NDD) associated with pathogenic CNV (Copy Number Variants) conference, EU COST action funded. Cardiff |
Year(s) Of Engagement Activity | 2022 |
URL | https://mindds.eu/activities/meetings/ |
Description | Co-organisation of conference |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Future MINDDS: Recent advances and future directions for research of Neurodevelopmental Disorders (NDD) associated with pathogenic CNV (Copy Number Variants) conference, EU-COST-funded. Cardiff |
Year(s) Of Engagement Activity | 2022 |
URL | https://mindds.eu/activities/meetings/ |
Description | Department of Education |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Schools |
Results and Impact | We discussed the plans for our Research Collaborative with the DoE and they wrote a letter to support our project. |
Year(s) Of Engagement Activity | 2021 |
Description | Discussions with Health and Care Research Wales |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Policymakers/politicians |
Results and Impact | We discussed with Health and Care Wales representatives our plans for our Research Collaborative grant. We received confirmation that proposal was interesting and addressed a clear area of need. |
Year(s) Of Engagement Activity | 2021 |
Description | Discussions with rare chromosome support charity Unique |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Patients, carers and/or patient groups |
Results and Impact | We discussed the plans for our Research Collaborative with Unique and they confirmed this is an important area of research and they wrote a letter to support our project. |
Year(s) Of Engagement Activity | 2021 |
Description | Discussions with support charity CEREBRA |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Patients, carers and/or patient groups |
Results and Impact | We discussed the plans for our Research Collaborative with CEREBRA and they confirmed this is an important area of research and they wrote a letter to support our project. |
Year(s) Of Engagement Activity | 2021 |
Description | Dr Megan Wood - Co-authored article for Greater Manchester Poverty Action (GMPA) newsletter |
Form Of Engagement Activity | A magazine, newsletter or online publication |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Public/other audiences |
Results and Impact | Co-authored article for monthly newsletter |
Year(s) Of Engagement Activity | 2023 |
URL | https://manchestercommunitycentral.org/sites/manchestercommunitycentral.org/files/GMPA%20Newsletter%... |
Description | Dr Megan Wood - Interview on BCB radio (Bradford Community Broadcasting) |
Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Public/other audiences |
Results and Impact | 20 min Radio interview by Dr Megan Wood about Child of the North Autism report. |
Year(s) Of Engagement Activity | 2024 |
URL | https://www.n8research.org.uk/media/CoTN_Autism_Report_1.pdf |
Description | Dr Megan Wood - Presented at Connected Yorkshire PPI meeting |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Patients, carers and/or patient groups |
Results and Impact | Presentation of EYFSP analyses to PPI group for Connected Yorkshire. |
Year(s) Of Engagement Activity | 2023 |
Description | Dr Megan Wood - Presented poster at UKPRP conference in Edinburgh |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Other audiences |
Results and Impact | Presented poster at conference. Discussed findings with delegates as well as networking. |
Year(s) Of Engagement Activity | 2023 |
Description | Dr Ruby Tsang's - Presentation to LINC's PPI advisory group |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Public/other audiences |
Results and Impact | Communicated latest research findings to PPI group, and received feedback from them. |
Year(s) Of Engagement Activity | 2023 |
Description | Dr Ruby Tsang's conference poster at Dementia's platform UK |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Other audiences |
Results and Impact | Poster presentation at Dementias Platform UK Translation 2023 Conference. |
Year(s) Of Engagement Activity | 2023 |
Description | Editorial team of special edition of 'Frontiers in Psychiatry' |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Special edition on a rare genetic condition. |
Year(s) Of Engagement Activity | 2022 |
Description | Festival of Social Science event |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Schools |
Results and Impact | We secured funding from the Economic and Social Research Council to run an event for pupils in Cardiff as part of the annual ESRC Festival of Social Science. 40 pupils from 4 secondary schools attended the event which focused on public health and genetic and environmental contributors to health across the lifespan. Pupils listened to talks and took part in activities, including evaluation of public health campaigns and a debating competition. Speakers included members of the research team, academic genetic counsellors and a local barrister. Students showed good engagement and school feedback was positive. Pupils' feedback reported their thoughts about their future careers had broadened from attending. The speakers and schools were interested in future involvement and volunteered to work with the team to widen access to future events to other pupils. |
Year(s) Of Engagement Activity | 2023 |
URL | https://www.cardiff.ac.uk/news/view/2785104-what-do-young-people-think-will-make-the-uk-a-healthier-... |
Description | Genetic Alliance |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Patients, carers and/or patient groups |
Results and Impact | We discussed the plans for our Research Collaborative with Genetic Alliance and they wrote a letter to support our project. |
Year(s) Of Engagement Activity | 2021 |
Description | Invited presentation on future of research into rare genomic variants. |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Presentation at the Future MINDDS: Recent advances and future directions for research of Neurodevelopmental Disorders (NDD) associated with pathogenic CNV (Copy Number Variants), conference, EU COST action-funded, Cardiff. |
Year(s) Of Engagement Activity | 2022 |
Description | Lectio Magistralis at the Festival Della Scienza, Genoa, Italy. |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | Presentation at Science Festival for ~300 people. |
Year(s) Of Engagement Activity | 2020 |
Description | Meeting with Dept of Education & Dept of Health and Social Care |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Policymakers/politicians |
Results and Impact | To share outcomes of the 'autism and neurodiversity' projects being undertaken in the Opportunity Areas and to provide insights into the learning from the projects. Most importantly, the meeting will shared learning about the way that the scientific insights have been applied to transform autism services by working with and through schools. To introduce LINC and it's aims to attendees and to establish a more formal Stakeholder Policy Group for the project which will serve to inform LINCs research and to influence practice and policy based on LINC's findings. Attended with Prof Mark Mon-Williams. |
Year(s) Of Engagement Activity | 2023 |
Description | Multimorbidity Scoping Workshop at Cardiff University |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Professional Practitioners |
Results and Impact | Workshop at Cardiff University brining together researchers and clinicians interested in the study of multimorbidity, where Prof van den Bree gave a presentation on LINC. |
Year(s) Of Engagement Activity | 2022 |
Description | PPI Group Meetings |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Patients, carers and/or patient groups |
Results and Impact | Continued quarterly meetings with LINC's PPI Group. Groups have been attended by several members of the LINC research team, including all post-docs and PhD students, and principal investigators. Team members will report back to the PPI group this year to share how their input has been incorporated into LINC research and informed findings. The group has also helped advise on the creation of communication materials. The current focus of the group is to create a LINC animation to explain and raise awareness of multimorbidity to wider audiences. Feedback from the PPI inspired the ESRC Festival of Social Sciences event due to many conversations we'd had with the group about how to communicate health risk to different age groups, particularly young people. These conversations continue, as well as those about the importance of communicating risk to different ethnic groups. |
Year(s) Of Engagement Activity | 2022,2023,2024 |
Description | Panel Member at Born in Bradford Festival |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Public/other audiences |
Results and Impact | Took part in Expert Panel discussing 'The role of education in improving outcomes for children and young people'. |
Year(s) Of Engagement Activity | 2023 |
URL | https://borninbradford.nhs.uk/news-events/events/bibfest-2023/ |
Description | Piece on our published work |
Form Of Engagement Activity | A press release, press conference or response to a media enquiry/interview |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Patients, carers and/or patient groups |
Results and Impact | Piece about our research in the newsletter of a national charity for families with a child with a brain condition. |
Year(s) Of Engagement Activity | 2023 |
URL | https://cerebra.org.uk/?mailpoet_router&endpoint=view_in_browser&action=view&data=WzE0OSwiNDYzMWU1MT... |
Description | Presentation at 'What I know best' congress, Rome, Italy |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Professional Practitioners |
Results and Impact | Presentation to Clinical Geneticists and other healthcare workers and those interested in genetics to provide an update of the field |
Year(s) Of Engagement Activity | 2021 |
Description | Presentation at All Wales Medical Genetic Service's Psychiatry & Genetics multidisciplinary team meetings |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | Presentation to provide an update on our research findings |
Year(s) Of Engagement Activity | 2021 |
Description | Presentation at rare chromosomal disorder MaxAppeal meeting |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Patients, carers and/or patient groups |
Results and Impact | Presentation about our research. |
Year(s) Of Engagement Activity | 2020 |
Description | Presentation on LINC multimorbidity Collaborative |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | A presentation about our LINC Multimorbidity Collaborative to the DEMISTIFY Multimorbidity Collaborative followed by discussions about opportunities for further collaboration. |
Year(s) Of Engagement Activity | 2023 |
Description | Presentation to Bristol Cleft Collective |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | Presentation about our research findings of the phenotypic features associated with having a rare chromosomal deletion or duplication (as Copy Number Variant). |
Year(s) Of Engagement Activity | 2023 |
Description | Presentation to Bristol Older People's Forum |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Public/other audiences |
Results and Impact | To raise awareness about health research on conditions related to aging, and opportunities to get involved - as PPI advisors or as study participants. The outcome was a hybrid event and new relationship building with members of the public and potential new PPI contributors, and new working relationship with the staff of Bristol Older People's Forum, who are interested in holding more such engagement events in future. |
Year(s) Of Engagement Activity | 2023 |
Description | Presentation to Cardiff MRC Centre for Neuropsychiatric Genetics and Genomics |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Other audiences |
Results and Impact | Presentation about the LINC multimorbidity programme to the Cardiff MRC Centre for Neuropsychiatric Genetics and Genomics, to increase awareness amongst academics. |
Year(s) Of Engagement Activity | 2022 |
Description | Presentation to Cardiff University School of Medicine Exec Committee |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Other audiences |
Results and Impact | Presentation about the LINC multimorbidity programme to the Cardiff School of Medicine Executive Committee to increase awareness amongst academics. |
Year(s) Of Engagement Activity | 2022 |
Description | Radio and television interest |
Form Of Engagement Activity | A broadcast e.g. TV/radio/film/podcast (other than news/press) |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Public/other audiences |
Results and Impact | Media interest about autism risk in individuals with rare genetic disorders. The Cardiff new item was picked up by 29 news sites, and over 40 radio and TV stations including Fox, CBS and ABC news, 4 blogs and had a twitter reach of >60,000 people. |
Year(s) Of Engagement Activity | 2021 |
URL | https://www.cardiff.ac.uk/news/view/2484687-clinical-criteria-for-diagnosing-autism-inadequate-for-p... |
Description | School outreach - Dr Ruby Tsang was on the judging panel at the ESRC Festival of Social Science Cardiff event. |
Form Of Engagement Activity | Participation in an activity, workshop or similar |
Part Of Official Scheme? | No |
Geographic Reach | Regional |
Primary Audience | Schools |
Results and Impact | Part of the debate judging panel at the ESRC Festival of Social Science Cardiff event. |
Year(s) Of Engagement Activity | 2023 |
URL | https://www.cardiff.ac.uk/news/view/2785104-what-do-young-people-think-will-make-the-uk-a-healthier-... |
Description | Social Media Linkedin / Twitter |
Form Of Engagement Activity | Engagement focused website, blog or social media channel |
Part Of Official Scheme? | No |
Geographic Reach | International |
Primary Audience | Media (as a channel to the public) |
Results and Impact | Network engagement - likes and shares of posts. |
Year(s) Of Engagement Activity | 2021,2022 |
Description | Workshop to shape the the Bradford Age of Wonder research programme. |
Form Of Engagement Activity | A formal working group, expert panel or dialogue |
Part Of Official Scheme? | No |
Geographic Reach | National |
Primary Audience | Professional Practitioners |
Results and Impact | Took part as invited expert in a workshop to discuss the design and foci of the newly Wellcome Trust funded 'Age of Wonder' research programme. This programme is linked to the LINC multimorbidity programme where the Born in Bradford cohort is one of the five LINC cohorts and LINC has close links with the Connect Bradford initiative. |
Year(s) Of Engagement Activity | 2022 |
Description | online presentation to members of the Carers Support Centre |
Form Of Engagement Activity | A talk or presentation |
Part Of Official Scheme? | No |
Geographic Reach | Local |
Primary Audience | Patients, carers and/or patient groups |
Results and Impact | Online meeting to raise awareness about health research on conditions that are more associated with ageing, and to build relationships to support Patient/Public Involvement (PPI) in future. |
Year(s) Of Engagement Activity | 2022 |